Daniel P Holt

Title: Inventor Spotlight: Daniel P. Holt

Introduction

Daniel P. Holt, based in Severna Park, MD, is a distinguished inventor with a focus on innovative solutions for the medical field. With two patents to his name, Holt has made significant contributions, particularly in the area of radiolabeled agents used in medical imaging and treatment.

Latest Patents

Holt's latest patents include the synthesis methods and related compositions for the radiolabeled prostate-specific membrane antigen (PSMA) inhibitor, known as [F]DCFPyL. These patents detail improved methods for synthesizing [F]DCFPyL and provide various applications for the produced composition, underscoring his commitment to advancing medical technology and diagnostics.

Career Highlights

Holt’s work is anchored at The Johns Hopkins University, where he applies his expertise in research and development. His role there has allowed him to stay at the forefront of medical innovation, contributing to the university’s reputation as a leader in research and clinical advancements.

Collaborations

Collaborating with esteemed colleagues such as Hayden T. Ravert and Ying Chen, Holt has fostered a productive research environment that encourages innovation. These partnerships not only enhance the quality of his work but also promote a multidisciplinary approach to solving complex medical challenges.

Conclusion

Daniel P. Holt exemplifies the spirit of innovation in the realm of medical inventions. His contributions through his patents and collaborations at The Johns Hopkins University reflect the importance of continued research and development in improving healthcare technologies. As he continues to make strides in his research, Holt’s work is poised to have a lasting impact on the medical field.